Healthcare - Biotechnology - NASDAQ - US
$ 0.33
9.63 %
$ 1.6 M
Market Cap
0.0
P/E
CASH FLOW STATEMENT
-25.2 M
OPERATING CASH FLOW
400 K
INVESTING CASH FLOW
26.1 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Panbela Therapeutics, Inc.
| Net Income | -25.3 M |
| Depreciation & Amortization | 168 K |
| Capital Expenditures | 0 |
| Stock-Based Compensation | 823 K |
| Change in Working Capital | -647 K |
| Others | -7.87 M |
| Free Cash Flow | -25.2 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Dec-2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||||||||
| Net Income | (25.3) | (34.9) | (10.1) | (4.8) | (6.2) | (5.9) | (10.4) | (5.1) | (4.9) | (0.1) | (0.2) | 0.2 | (0.1) |
| Depreciation & Amortization | 0 | 0 | 0 | 0.1 | 2.1 | 0 | 0 | 28 K | 28 K | 9.58 K | 8.79 K | 5.64 K | 3.1 K |
| Deferred Income Tax | 0 | 0 | 0 | (0.1) | (2.1) | 0 | 0 | 0 | (1.0) | 0 | 0 | 833 | 0 |
| Stock Based Compensation | 0.8 | 1.1 | 1.3 | 1.2 | 1.1 | 1.3 | 1.7 | 0.9 | 1.0 | 196 | 600 | 600 | 600 |
| Other Operating Activities | (0.2) | 18.0 | 0.6 | (0.1) | 2.2 | 1.7 | 5.3 | 12 K | 1.0 | 34 K | 0.1 | 0.1 | 0.2 |
| Change in Working Capital | (0.6) | 0.6 | 2.1 | (0.2) | 0.2 | 0.5 | 62 K | 1.8 | 26 K | 52 K | 52.9 K | (0.3) | (0.1) |
| Cash From Operations | (25.2) | (15.3) | (6.7) | (3.9) | (2.7) | (2.4) | (3.4) | (2.4) | (3.9) | 11.5 K | 35.4 K | 37.1 K | 73 K |
| INVESTING CASH FLOW | |||||||||||||
| Capital Expenditures | 0 | (0.7) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.12 K | 0 | 9.53 K |
| Other Items | 0.4 | 4 K | (0.5) | 0 | 0 | 0 | 0 | 0 | 0.5 | 0.1 | 0 | 19.1 K | 0 |
| Cash From Investing Activities | 0.4 | (0.7) | (0.5) | 0 | 0 | 0 | 0 | 0 | 0.5 | 0.1 | 5.12 K | 19.1 K | 9.53 K |
| FINANCING CASH FLOW | |||||||||||||
| Common Stock Repurchased | 10 K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | (1.6) | 0 | 0 | 0 | 0.6 | 1.3 | 3.1 | 0 | 0 | 2.4 | 0 | 6.85 K | 8.9 K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 4.7 | 5 K | 1.0 | (0.6) | 0 | 0 | 47 K | 42 K | 1.2 | (2.4) | 11.6 K | 0 | 0 |
| Cash From Financing Activities | 26.1 | 5.4 | 10.1 | 10.4 | 3.8 | 3.6 | 3.11 K | 1.92 K | 2.68 K | 8.32 K | 11.6 K | 6.85 K | 8.9 K |
| CHANGE IN CASH | |||||||||||||
| Net Change In Cash | 1.3 | (10.6) | 2.8 | 6.6 | 1.0 | 1.3 | (0.3) | (0.5) | (0.7) | 0.1 | 52.1 K | 63.1 K | 73.7 K |
| FREE CASH FLOW | |||||||||||||
| Free Cash Flow | (25.2) | (15.9) | (6.7) | (3.9) | (2.7) | (2.4) | (3.4) | (2.4) | (3.9) | 11.5 K | 40.5 K | 37.1 K | 82.6 K |